Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
34,01 USD | +7,19 % | -4,17 % | -5,26 % |
Resumen de negocios
Número de empleados: 103 605
Ventas por actividad
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83 % |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43 % |
Ventas por región
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28 % |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05 % |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76 % |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81 % |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52 % |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81 % |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26 % |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09 % |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01/01/20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01/01/15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01/04/20 |
General Counsel | 60 | 01/04/20 | |
Human Resources Officer | 57 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17/03/20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05/03/19 |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14/03/17 |
Director/Board Member | 58 | 01/03/16 | |
Jemilah Mahmood
BRD | Director/Board Member | - | - |
Akiko Iwasaki
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Acción B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
1 005 670 000 | 59.89% | 30 596 634 817 $ | |
ROCHE HOLDING AG 1.43% | 10 073 029 | 1.43% | 2 579 249 239 $ |
2 744 120 | 7.42% | 42 451 536 $ | |
454 961 | 3.02% | 11 810 788 $ | |
ALIGOS THERAPEUTICS, INC. 14.70% | 11 025 941 | 14.70% | 6 505 305 $ |
1 893 | 0.06% | 1 609 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Viewics India Pvt Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Sapac Corp. Ltd.
|
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+55,32 % | 815 mil M | |
-6,75 % | 352 mil M | |
+13,56 % | 314 mil M | |
+10,68 % | 303 mil M | |
+16,57 % | 242 mil M | |
+13,31 % | 218 mil M | |
+8,48 % | 168 mil M | |
-2,81 % | 159 mil M | |
+0,20 % | 120 mil M |
- Bolsa de valores
- Acciones
- Acción ROG
- Acción 0TDF
- Empresa Roche Holding AG